BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2015
View Archived Issues
Novel inhibitors of InhA show promising results for the treatment of MDR-TB
Read More
Ipsen reports topline phase III data on Dysport in lower limb spasticity
Read More
FDA approves Natpara for treatment of hypocalcemia in patients with hypoparathyroidism
Read More
EMA CHMP recommends approval of lamivudine/raltegravir for HIV-1 infection
Read More
Torii files Japanese NDA for sublingual immunotherapy for dust mite allergy
Read More
Five Prime Therapeutics reviews product development
Read More
CDK inhibitors disclosed by Bayer
Read More
Japan Tobacco divulges novel PDHK inhibitors
Read More
Dosing begins in phase I/II trial of SBC-103 in mucopolysaccharidosis IIIB
Read More
FDA approves Triferic for iron replacement and hemoglobin maintenance in CKD
Read More
BMS patents novel indoleamine 2,3-dioxygenase 1 inhibitors
Read More
Insys Therapeutics receives U.S. orphan drug designation for liposomal encapsulated paclitaxel
Read More
Researchers from Genentech and Roche disclose new BTK inhibitors
Read More
Sichuan Haisco presents novel FFAR1 agonists for diabetes
Read More
Gem Pharmaceuticals enrolls patients in phase II GPX-150 trial in sarcoma
Read More
Lion Biotechnologies amends CRADA with NCI to include new cancer indications
Read More
New cytidine analogue inhibits gemcitabine-resistant tumor cell growth
Read More
Phase I data for ABT-700 in GEC patients
Read More
BIRD Foundation grant supports Orgenesis and Pall's efforts in diabetes
Read More
EMA grants orphan drug designation to ApoCell for GVHD
Read More
Takeda launches fomepizole in Japan for ethylene glycol and methanol poisoning
Read More
Opsona Therapeutics initiates phase I/II trial of OPN-305 in myelodysplastic syndrome
Read More
FDA grants fast track designation to BCX-4161 for hereditary angioedema
Read More
FDA grants orphan drug status to Antroquinonol for pancreatic cancer
Read More
EMA adopts positive opinion on Ikervis eye drops
Read More